Rheumatology Doctors in Plymouth, MA Accepting Medicare

4 Rheumatology doctors found. Showing 1 - 4

Senada Arabelovic, DO Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 45 Resnik Rd, Plymouth, MA 02360 Phone: 508-746-5351

Tanya Doan, MD Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 45 Resnik Rd, Ste 203, Plymouth, MA 02360 Phone: 508-746-5351    Fax: 508-747-3299

Dr. Philip Joseph Molloy Iv, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 45 Resnik Rd, Suite 203, Plymouth, MA 02360 Phone: 508-746-5351    Fax: 508-747-3299

Dr. Rachel Lauren Gross, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 110 Long Pond Rd, Suite 106, Plymouth, MA 02360 Phone: 508-746-5351    Fax: 508-747-3299

News Archive

Michigan Senate approves expansion of Medicaid

The vote was a victory for Republican Gov. Rick Snyder, who pushed for passage, bucking the sentiments of many in his party. It is now all but certain that nearly half a million residents will gain coverage when Michigan joins the list of states opting to expand the program under the federal health law.

Australian research looks at hospital acquired medical complications

A new study has shown that one in nine Australian patients who were hospitalized between 2012 and 2015, suffered from one or the other hospital acquired complication. These complications are usually of a preventable nature and occur when there is a deficiency in patient care.

Lupin's Famotidine for Oral Suspension receives FDA approval

Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received final approval from the US Food and Drug Administration (FDA) for its Famotidine for Oral Suspension (40 mg / 5 mL). Commercial shipments of the product have already commenced.

Allergan's sNDA for TEFLARO (ceftaroline fosamil) accepted by FDA

Allergan plc today announced the U.S. Food and Drug Administration has accepted for filing the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil).

Read more Medical News

› Verified 1 days ago